Veterinary Industry’s 2020 growth comes with a human cost
New research from CM Research & WSAVA shows that whilst revenues and client numbers are increasing, staff are squeezed due to supply & stock issues and the burden of measures in place to manage the pandemic .
Key findings
- Despite the challenges and new ways of working created by the pandemic, for many clinics client numbers are increasing – especially in North America and Australia.
- The financial impact on clinics has been varied, with certain regions/countries reporting notably better figures than others. Australia and the USA stand out as the two countries where clinics have seen the strongest growth.
- While veterinary professionals in Australia and New Zealand have a positive outlook on the future and believe we are now coming out of the pandemic, the overall feeling globally is more pessimistic.
- Issues with stock and the supply chain have been widespread, especially in North America. Pharmaceutical products and PPEs are the areas most affected.
- Clinic activities have also shifted, with offerings such as home visits and routine check-ups typically reduced or stopped altogether in most regions. Pet vaccination levels have also dropped, especially in Western Europe.